U.S. flag

An official website of the United States government

NM_003242.6(TGFBR2):c.1562G>A (p.Trp521Ter) AND Loeys-Dietz syndrome 2

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003153131.1

Allele description [Variation Report for NM_003242.6(TGFBR2):c.1562G>A (p.Trp521Ter)]

NM_003242.6(TGFBR2):c.1562G>A (p.Trp521Ter)

Gene:
TGFBR2:transforming growth factor beta receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p24.1
Genomic location:
Preferred name:
NM_003242.6(TGFBR2):c.1562G>A (p.Trp521Ter)
HGVS:
  • NC_000003.12:g.30691457G>A
  • NG_007490.1:g.89956G>A
  • NM_001024847.3:c.1637G>A
  • NM_001407126.1:c.1745G>A
  • NM_001407127.1:c.1670G>A
  • NM_001407128.1:c.1589G>A
  • NM_001407129.1:c.1565G>A
  • NM_001407130.1:c.1559G>A
  • NM_001407132.1:c.1457G>A
  • NM_001407133.1:c.1457G>A
  • NM_001407134.1:c.1457G>A
  • NM_001407135.1:c.1457G>A
  • NM_001407136.1:c.1457G>A
  • NM_001407137.1:c.1277G>A
  • NM_001407138.1:c.1202G>A
  • NM_001407139.1:c.692G>A
  • NM_003242.6:c.1562G>AMANE SELECT
  • NP_001020018.1:p.Trp546Ter
  • NP_001020018.1:p.Trp546Ter
  • NP_001394055.1:p.Trp582Ter
  • NP_001394056.1:p.Trp557Ter
  • NP_001394057.1:p.Trp530Ter
  • NP_001394058.1:p.Trp522Ter
  • NP_001394059.1:p.Trp520Ter
  • NP_001394061.1:p.Trp486Ter
  • NP_001394062.1:p.Trp486Ter
  • NP_001394063.1:p.Trp486Ter
  • NP_001394064.1:p.Trp486Ter
  • NP_001394065.1:p.Trp486Ter
  • NP_001394066.1:p.Trp426Ter
  • NP_001394067.1:p.Trp401Ter
  • NP_001394068.1:p.Trp231Ter
  • NP_003233.4:p.Trp521Ter
  • LRG_779t1:c.1637G>A
  • LRG_779t2:c.1562G>A
  • LRG_779:g.89956G>A
  • LRG_779p1:p.Trp546Ter
  • LRG_779p2:p.Trp521Ter
  • NC_000003.11:g.30732949G>A
  • NM_001024847.2:c.1637G>A
Protein change:
W231*
Molecular consequence:
  • NM_001024847.3:c.1637G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407126.1:c.1745G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407127.1:c.1670G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407128.1:c.1589G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407129.1:c.1565G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407130.1:c.1559G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407132.1:c.1457G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407133.1:c.1457G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407134.1:c.1457G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407135.1:c.1457G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407136.1:c.1457G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407137.1:c.1277G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407138.1:c.1202G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001407139.1:c.692G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_003242.6:c.1562G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Loeys-Dietz syndrome 2 (LDS2)
Synonyms:
Loeys-Dietz syndrome type 1B; MARFAN SYNDROME, TYPE II; Loeys-Dietz syndrome type 2B; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0012427; MedGen: C2674574; Orphanet: 558; OMIM: 610168

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0038419423billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 23, 2023)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.

Stheneur C, Collod-BĂ©roud G, Faivre L, Gouya L, Sultan G, Le Parc JM, Moura B, Attias D, Muti C, Sznajder M, Claustres M, Junien C, Baumann C, Cormier-Daire V, Rio M, Lyonnet S, Plauchu H, Lacombe D, Chevallier B, Jondeau G, Boileau C.

Hum Mutat. 2008 Nov;29(11):E284-95. doi: 10.1002/humu.20871.

PubMed [citation]
PMID:
18781618

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From 3billion, SCV003841942.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. This variant was predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by less than 10%. The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (PMID: 18781618). The variant has been reported to be associated with TGFBR2 -related disorder (PMID: 18781618). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 26, 2023